Quick Facts

• Relieves symptoms associated with allergies, such as sneezing and watery eyes.
• Addresses allergic dermatological reactions, including hives (urticaria).
• Manages conditions related to excessive stomach acid.
• Treats upper gastrointestinal conditions, such as acid reflux and peptic ulcer.

Histacetyl: Uses and Therapeutic Benefits

Histacetyl is a medication indicated to address conditions mediated by histamine, a natural substance in the body. Depending on its specific target, it offers therapeutic benefits for two primary areas of health.

One main use is to relieve the symptoms of allergies. This includes managing allergic rhinitis, which can cause sneezing, a runny nose, and watery eyes. It is also used to address allergic dermatological reactions, such as urticaria (hives) and angioedema (swelling beneath the skin).

A separate therapeutic application is the management of conditions caused by excessive stomach acid. Histacetyl can be used to treat upper gastrointestinal conditions, including acid reflux (heartburn) and peptic ulcer. It may also manage gastritis (stomach lining inflammation) and certain hypersecretory conditions, such as Zollinger-Ellison syndrome.

Who Can and Cannot Use Histacetyl? - Official Regulatory Information

The eligibility for Histacetyl, an antimicrobial combination of a Nitroimidazole and a Macrolide, is strictly determined by official regulatory criteria, defining specific populations for whom use is allowed, restricted, or absolutely prohibited.

Populations for Whom Use is Contraindicated

Official regulatory documents state that Histacetyl must not be used in the following groups:

• Animals with known hypersensitivity (allergy) to either of the active substances (Nitroimidazole or Spiramycin) or any excipients.
• Animals with pre-existing hepatic disorders (liver impairment or disease).

Eligibility Status by Physiological Condition

Use is not recommended during both pregnancy and lactation, as both components of the medicine are known to be excreted in milk, aligning with regulatory caution for the reproductive period. The medicine is exclusively authorized for the dog population.

Histacetyl is a combination product containing spiramycin, a macrolide antibiotic, and dimetridazole, a nitro-imidazole component. The interaction profile of Histacetyl is defined by the known properties of its active ingredients, specifically advising against certain combinations to avoid potential adverse effects or reduced efficacy.

Documented Pharmacological Interactions

Key Interaction Restrictions

Healthcare professionals are directed not to combine Histacetyl with lincosamide antibiotics or with bactericidal antibiotics active on multiplying bacteria. This restriction is based on the risk of compromised treatment effectiveness due to the specific microbial resistance mechanisms associated with macrolides, and the potential for reduced activity when bacteriostatic and bactericidal agents are used together. No specific timing-based administration rules or population-specific interaction adjustments are explicitly documented for this product's use in combination with other medicines.

Histacetyl acts mechanistically via two principal biological targets: the Histamine H1 receptor and the enzyme Acetylcholinesterase (AChE). The compound functions as an inverse agonist at the H1 receptor, stabilizing the inactive receptor conformation to suppress basal constitutive activity and prevent the binding of endogenous histamine. This action modulates the intracellular Gq-protein signaling pathway, diminishing downstream phospholipase C activation and the resultant mobilization of intracellular calcium. Simultaneously, the compound serves as a non-competitive inhibitor of AChE. By binding to the enzyme, it prevents the enzymatic hydrolysis of the neurotransmitter acetylcholine (ACh), leading to a localized increase in ACh concentration within cholinergic synapses. This elevated synaptic ACh enhances and prolongs signal transmission via both muscarinic and nicotinic receptors in the peripheral and central nervous systems, resulting in systemic modulation of cholinergic tone and neuromuscular function.

Histacetyl is administered exclusively through the oral route as a fixed-dose comprimé (tablet), which contains a combination of Dimetridazole and Spiramycin. The use of this medicine is structured around a fixed daily dose and a mandated treatment duration.

The standard regimen for target animals requires administration once daily (Q.D.) for a fixed course of seven consecutive days. This pattern is mandated for the completion of the antimicrobial course. The required dose is calculated based on body weight, aiming for a total of 25 mg of combined active ingredients per kilogram of body weight, with the product label setting a maximum daily intake of 375 mg.

To standardize intake, the tablet must be given with food to optimize the systemic absorption of Spiramycin. Furthermore, the dose should be administered at a consistent time each day to maintain stable drug levels. The tablet should not be divided unless it possesses a functional score line, as doing so may lead to dosing inaccuracies.

Dosing guidelines also address specific physiological conditions. For target animals exhibiting hepatic impairment, an official dose reduction of 50% is required to account for changes in drug metabolism. Additionally, the medicine is generally not recommended for use in animals under six months of age due to differing metabolic rates.

Research Evidence / Overview of Studies for Histacetyl

Evidence for Use in Peptic Ulcer Disease and Acid Reflux

Research has explored the evaluation of this drug class in conditions such as peptic ulcers and acid reflux (GERD) through many well-designed Randomized Controlled Trials (RCTs). These studies were designed to evaluate how outcomes related to physical discomfort and functional imbalance were examined over a defined time interval. Findings describe patterns observed in the studies related to ulcer healing during the study period, particularly when compared to a placebo. Studies also report how acid secretion evolved in the observed populations, indicating patterns related to acid secretion itself. Data covering long-term outcomes is not fully established based on the strongest trial designs, and follow-up durations were limited.

Evidence for Adjunctive Use in Allergic Dermatological Reactions

Research has explored the use of this medication in connection with allergic dermatological reaction(s), such as chronic urticaria (hives), in studies using different research designs. The available evidence is limited, primarily consisting of smaller RCTs and subsequent retrospective studies, focusing on patients whose symptoms persisted despite standard treatments. The certainty remains limited regarding the patterns observed with this medicine for allergic conditions, as the evidence quality varies and trials often involved modest sample sizes.

Evidence for Antimicrobial Use in Animals

The research base for the combination antimicrobial component of Histacetyl involves studies that examined its evaluation in target animal groups, specifically dogs. This research explored its application in conditions such as certain bucco-dental affections related to susceptible protozoal or anaerobic bacteria. The evidence structure is based on In Vivo Canine Studies and In Vitro Microbiological Studies. Data for certain groups of animals remain insufficient, and the research often relies on evidence associated with a similar, though not identical, nitroimidazole component.

Key Studies & References Systematic Review of H2 Receptor Antagonists for the Treatment of Peptic Ulcer Disease

Common questions about Histacetyl (FAQ)

Q: What is the main reason Histacetyl is prescribed?

According to official regulatory documents, Histacetyl is authorized as a treatment medicine. Its general purpose is defined as countering and halting the proliferation of susceptible protozoal and anaerobic bacterial infections in the target species.

Q: Is Histacetyl considered a type of antihistamine?

Histacetyl is officially classified as a Combination Antibiotic, deriving its efficacy from a macrolide and a nitroimidazole component. While official information indicates one component acts on the H1 histamine receptor, the medicine is not categorized as an antihistamine drug.

Q: Is Histacetyl the same as [Name of similar, known drug]?

Histacetyl is a unique veterinary-specific product authorized for use in the target species. It contains a specific combination of Dimetridazole and Spiramycin, which sets it apart from other similar combination antimicrobial products, including human analogues.

Q: What are the most frequent side effects listed for Histacetyl?

The majority of documented adverse effects for Histacetyl are officially categorized as having a Rare or Very Rare incidence. These low-incidence categories include gastrointestinal disturbances like vomiting and diarrhea. The available frequency data primarily reports these low rates.

Q: Are there restrictions on taking Histacetyl if I have kidney issues?

Official regulatory documents advise using Histacetyl with caution in the presence of existing renal dysfunction (kidney issues). While pre-existing kidney disease is not listed as an absolute contraindication, the product label advises caution.

Q: What are the major warnings listed on the Histacetyl package insert?

Official regulatory documentation includes major safety warnings. Official safety notes address the potential for signs of neurotoxicity (nerve damage) when treatment duration is prolonged. Additionally, the label covers the potential for genotoxicity and mutagenic properties observed in laboratory studies.

Q: Is Histacetyl safe to take long-term?

The official documentation requires a fixed, short-term treatment course for Histacetyl, often seven consecutive days. Regulatory warnings about certain adverse effects, like neurotoxicity, note that they occur primarily after prolonged administration. Therefore, the medicine's use is not authorized beyond the specified short treatment course.

Q: Is Histacetyl generally well-tolerated?

The safety profile, as established by regulatory documentation, indicates that the documented adverse effects are primarily categorized as Rare or Very Rare in incidence. This classification suggests a profile where most individuals experience a low rate of side effects.

Q: What is the risk of having a serious allergic reaction to Histacetyl?

Official documentation for Histacetyl notes that hypersensitivity reactions, which are types of allergic reactions, fall under the classification of Rare adverse effects. Known hypersensitivity to the active ingredients is listed as a contraindication.

Q: How is Histacetyl different from a standard over-the-counter medicine for similar symptoms?

Histacetyl is an oral prescription combination product that draws its activity from two powerful antibiotic substances. This dual composition and its specific authorization as a combination antimicrobial distinguish it from standard single-agent over-the-counter remedies.

Q: Are there different strengths or formulations of Histacetyl?

The medicine is supplied as an oral fixed-dose tablet (comprimé). However, similar combination products in veterinary medicine are often authorized in multiple strengths to allow for accurate dosing based on body weight.

Q: How does the effect of Histacetyl change over time?

The therapeutic effect requires use over a fixed, consecutive course, typically seven days. Pharmacokinetic studies indicate that the active components in the blood reach their peak concentration within approximately 1.3 to 1.4 hours after the tablet is given.

Q: Is Histacetyl a preventative or a treatment medicine?

Histacetyl is authorized as a treatment medicine. Its general purpose is to counter and halt the proliferation of susceptible protozoal and anaerobic bacterial infections that are already present in the target species.

Q: How quickly should I expect to feel a change after starting Histacetyl?

Pharmacokinetic studies indicate that the active ingredients reach their peak concentration in the blood within approximately 1.3 to 1.4 hours after the oral dose is administered. This indicates when the active components are most concentrated in the system.

Q: Does Histacetyl cause drowsiness or fatigue?

As one component acts on the histamine H1 receptor, side effects commonly reported for this class of medicine include central nervous system effects such as drowsiness, fatigue, and impaired concentration.

Q: Can Histacetyl affect my sleep?

Official information indicates that medicines acting on the histamine H1 receptor have the potential to influence the sleep/wake cycle. This mechanism means the medicine may result in altered sleep patterns in some individuals.

Q: How long does Histacetyl stay in your system?

Pharmacokinetic data shows that the terminal half-lives of the active components range from approximately 5.3 hours to 8.6 hours in the target species. The presence of the drug can therefore be detected in the system for at least several times the longest half-life.

Q: If I miss a dose of Histacetyl, what is the generally accepted advice?

Regulatory advice for antimicrobial courses usually directs users to administer the missed dose as soon as it is remembered. Users should then resume the regular administration schedule for the remainder of the fixed course.

Q: What does 'contraindicated' mean in relation to Histacetyl?

A contraindication is a specific circumstance or health condition where the medicine should not be used because it carries a high risk of harm or could worsen a pre-existing condition. For Histacetyl, a pre-existing hepatic disorder is an example of a contraindication.

Q: Are there any specific foods or drinks that should be avoided while on Histacetyl?

The official product label requires the tablet to be given with food to optimize absorption. However, the regulatory documentation does not list any specific foods or drinks that must be avoided while administering the medicine.

Q: What happens if I stop taking Histacetyl suddenly?

Discontinuing the mandated course of an antibiotic early is associated with a risk of developing antimicrobial resistance. No specific withdrawal symptoms are typically listed for the components after the conclusion of a standard short course.

Q: Does Histacetyl interact with alcohol?

The Nitroimidazole component in Histacetyl belongs to a drug class that has a known interaction with alcohol. This interaction, known as the disulfiram-like reaction, is a widely documented concern associated with this class of drugs.

Q: Does Histacetyl affect my ability to concentrate?

Side effects associated with the medicine's H1-histamine receptor component can include effects on the central nervous system. These documented effects include the potential for impaired concentration.

Q: What is the difference between an 'interaction' and a 'contraindication' for Histacetyl?

An interaction occurs when another substance alters the intended effect of Histacetyl, either increasing or decreasing its action. A contraindication is a pre-existing condition that means the medicine should not be used at all because of the risk of harm.

Q: Can Histacetyl cause changes in mood or behavior?

CNS-related adverse effects are associated with the H1-receptor component. These effects may include changes in mental state, such as agitation or restlessness, in susceptible individuals.

Q: Does Histacetyl have a Black Box Warning?

The term Black Box Warning is specific to U.S. human labels. However, the regulatory documentation does contain explicit, major safety warnings that include the potential for neurotoxicity and notes on carcinogenic/mutagenic properties observed in laboratory studies.

How to Store and Dispose of Histacetyl?

Histacetyl must be stored according to regulatory requirements to ensure its stability. The product should not be stored above 30 °C and requires protection from both light and moisture. The tablets must remain in the original container or blister packaging to preserve product integrity.

Stability and Safety

The shelf life of the full product is typically 18 months. Any divided tablet must be used within 3 days. For safety, the medicine must be stored out of the sight and reach of children and target animals.

Disposal Instructions

Disposal of unused or expired Histacetyl must adhere to local requirements for pharmaceutical waste. The product must not be disposed of via household waste or flushed down wastewater drains, as this can lead to environmental contamination.